France

Signadori Bio raises €11M to advance Monocyte-Based Cancer Immunotherapies
French biotech startup Signadori Bio has secured a total of €11.1 million in Seed financing to accelerate the development of its next-generation immunotherapy platform targeting solid tumours.

The best Articles in our Network